Dr. Jennifer Van Eyk received her PhD from University of Alberta Canada and carried out PDF in Heidelberg, Germany and Chicago, USA. She started her lab at Queen’s University, Kingston Canada, was recruited to Johns Hopkins University and finally to Cedars-Sinai Medical Center. There she directs the Advanced Clinical BioSystems Research Institute which has the motto, “from discovery to patient care”. Her research focuses on acute and chronic disease to i) understanding the molecular mechanisms for the development of precision therapies and ii) in the development of clinically robust circulating biomarkers for personalization of medical care. As part of this effort she directs the Precision Biomarker Laboratories to move assay into clinical chemistry lab for broad adoption.